Treatment‐resistant tinea corporis, a potential public health issue-Reference-Cited by-同舟云学术

Treatment‐resistant tinea corporis, a potential public health issue

Published:2020-09-16 Issue:1 Volume:184 Page:164-165
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Chen E.¹^ORCID,Ghannoum M.²,Elewski B.E.¹^ORCID

Affiliation:

1. Department of Dermatology University of Alabama at Birmingham Birmingham AL USA

2. Department of Dermatology Case Western Reserve University and University Hospitals Cleveland Medical Center Cleveland OH USA

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19420

Reference8 articles.

1. Clinical and Laboratory Standards Institute.Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Available at:https://clsi.org/standards/products/microbiology/documents/m38/(last accessed 31 July 2020).

2. The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive?

3. Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to Terbinafine

4. Darier Disease Complicated by Terbinafine-resistant Trichophyton rubrum: A Case Report

5. Potential of Ergosterol Synthesis Inhibitors To Cause Resistance or Cross-Resistance in Trichophyton rubrum

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae;Journal of the American Academy of Dermatology;2024-08

2. Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis;Expert Review of Anti-infective Therapy;2024-06-02

3. Time to Think Antifungal Resistance;Pathogens and Immunity;2024-03-05

4. Dermatophyte Infections Worldwide: Increase in Incidence and Associated Antifungal Resistance;Life;2023-12-19

5. Multidrug resistant tinea corporis/cruris: Response to voriconazole;Journal of Medical Mycology;2022-11